UPDATE: Ladenburg Thalmann Starts Kiora Pharmaceuticals (KPRX) at Buy, 'attractive investment opportunity', PT $6.50
Tweet Send to a Friend
(Updated - August 25, 2022 7:03 AM EDT)
Ladenburg Thalmann initiates coverage on Kiora Pharmaceuticals (NASDAQ: KPRX) with a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Ladenburg Thalmann initiates coverage on Kiora Pharmaceuticals (NASDAQ: KPRX) with a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
